anti-HBXIP (HBXIP) Antikörper

Bezeichnung:
anti-Hepatitis B Virus X-Interacting Protein Antikörper (HBXIP)
Auf www.antikoerper-online.de finden Sie aktuell 3 Hepatitis B Virus X-Interacting Protein (HBXIP) Antikörper von 2 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen HBXIP Kits (7) und HBXIP Proteine (5) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 17 HBXIP Produkte verfügbar.
Synonyme:
1110003H18Rik, Hbxip, XIP
Alle Antikörper anzeigen Gen GeneID UniProt
HBXIP 10542 O43504
HBXIP 68576 Q9D1L9
HBXIP 295357  

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-HBXIP (HBXIP) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human HBXIP Antikörper:

anti-Mouse (Murine) HBXIP Antikörper:

anti-Rat (Rattus) HBXIP Antikörper:

Alle verfügbaren anti-HBXIP Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Weitere Antikörper gegen HBXIP Interaktionspartner

Cow (Bovine) Hepatitis B Virus X-Interacting Protein (HBXIP) Interaktionspartner

  1. Overall, the available data depict a self-inhibitory feedback loop in which HBV, through HBx, increases the expression of miR (zeige MYLIP Antikörper)-125a, that in turn interferes with expression of HBV surface antigen, thus repressing viral replication.

Human Hepatitis B Virus X-Interacting Protein (HBXIP) Interaktionspartner

  1. deacetylation of MST1 mediated by HBXIP-enhanced HDAC6 results in MST1 degradation in a CMA manner in promotion of breast cancer growth.

  2. HBXIP up-regulates YAP (zeige YAP1 Antikörper) expression via activating transcription factor c-Myb (zeige MYB Antikörper) to facilitate the growth of hepatoma cells.

  3. high level of expression of HBXIP is associated with the progression of non-small-cell lung cancer and may be a useful biomarker for poor prognostic evaluation and a potential molecular therapy target for patients with non-small-cell lung cancer

  4. HBXIP is able to depress the gluconeogenesis in hepatoma cells by suppressing PCK1 (zeige PCK1 Antikörper) to promote hepatocarcinogenesis, involving miR (zeige MLXIP Antikörper)-135a/FOXO1 (zeige FOXO1 Antikörper) axis and PI3K (zeige PIK3CA Antikörper)/Akt (zeige AKT1 Antikörper)/p-FOXO1 (zeige FOXO1 Antikörper) pathway.

  5. we conclude that the oncoprotein HBXIP contributes to the abnormal lipid metabolism in breast cancer

  6. HBXIP can function as a mediator protein for DNA damage response signals to activate the G2/M checkpoint to maintain genome integrity and prevent cell death.

  7. promotes cisplatin resistance and regulates CD147 via Sp1 (zeige PSG1 Antikörper) in ovarian cancer

  8. The mRNA levels of ACSL1 (zeige Acsl1 Antikörper) were positively associated with those of HBXIP in clinical breast cancer tissues. Thus, we conclude that the oncoprotein HBXIP is able to up-regulate ACSL1 (zeige Acsl1 Antikörper) through activating the transcriptional factor Sp1 (zeige PSG1 Antikörper) in breast cancer.

  9. Data indicate that hepatitis B virus X-interacting protein (HBXIP) over-expression appears to associate with cervical cancer progression, and may potentially be used as a cervical cancer biomarker for the early diagnosis, prognostic evaluation and therapeutic target for cervical cancer.

  10. Multivariate analysis indicated that HBXIP, in addition to the clinical stage, was a significant independent prognostic factor in patients with ovarian cancer.

HBXIP Antigen-Profil

Beschreibung des Gens

This gene encodes a protein that specifically complexes with the C-terminus of hepatitis B virus X protein (HBx). The function of this protein is to negatively regulate HBx activity and thus to alter the replication life cycle of the virus.

Alternative names and synonyms associated with HBXIP

  • hepatitis B virus x interacting protein (HBXIP) Antikörper
  • Hepatitis B virus X-interacting protein (xip) Antikörper
  • hepatitis B virus x interacting protein (LAMTOR5) Antikörper
  • late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 (LAMTOR5) Antikörper
  • late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 (Lamtor5) Antikörper
  • late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 (HBXIP) Antikörper
  • 1110003H18Rik Antikörper
  • Hbxip Antikörper
  • XIP Antikörper

Bezeichner auf Proteinebene für HBXIP

hepatitis B virus x interacting protein , hepatitis B virus x-interacting protein , Hepatitis B virus X-interacting protein , HBV X-interacting protein homolog , HBX-interacting protein homolog , hepatitis B virus X-interacting protein homolog , late endosomal/lysosomal adaptor and MAPK and MTOR activator 5 , ragulator complex protein LAMTOR5 , HBV X-interacting protein , HBx-interacting protein , hepatitis B virus x-interacting protein (9.6kD) , Hepatitis B virus X-interacting protein homolog

GENE ID SPEZIES
419811 Gallus gallus
457120 Pan troglodytes
701645 Macaca mulatta
100196036 Salmo salar
100301744 Oncorhynchus mykiss
516090 Bos taurus
10542 Homo sapiens
68576 Mus musculus
295357 Rattus norvegicus
448965 Sus scrofa
479907 Canis lupus familiaris
Ausgewählte Anbieter für anti-HBXIP (HBXIP) Antikörper
Haben Sie etwas anderes gesucht?